{"id":26239,"date":"2023-02-10T09:19:25","date_gmt":"2023-02-10T09:19:25","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/sk\/?page_id=26239"},"modified":"2025-09-09T10:55:25","modified_gmt":"2025-09-09T10:55:25","slug":"miguel-barrero","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero","title":{"rendered":"MIGUEL BARRERO"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/mbarrero\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Miguel Barrero<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Miguel Barrero Dur\u00e1n je riadite\u013eom pre rozvoj podnikania a inov\u00e1cie a do spolo\u010dnosti Neuraxpharm nast\u00fapil v roku 2015, kde vytvoril a rozv\u00edjal firemn\u00e9 oddelenia rozvoja podnikania a licenci\u00ed, riadenia alianci\u00ed a potrubia. Miguel tie\u017e vedie oddelenia du\u0161evn\u00e9ho vlastn\u00edctva a zdravotn\u00edckych pom\u00f4cok. Miguel m\u00e1 25 rokov sk\u00fasenost\u00ed vo farmaceutickom priemysle na r\u00f4znych poz\u00edci\u00e1ch a v r\u00f4znych spolo\u010dnostiach. svoju profesion\u00e1lnu kari\u00e9ru za\u010dal v roku 2000 v spolo\u010dnosti Almirall, po ktorej nasledovala spolo\u010dnos\u0165 Merck Serono v roku 2005 a spolo\u010dnos\u0165 Esteve v roku 2008, kde pracoval na ved\u00facich poz\u00edci\u00e1ch vo farmaceutickom v\u00fdvoji, \u010do mu poskytlo rozsiahle technick\u00e9 a vedeck\u00e9 z\u00e1zemie. pred n\u00e1stupom do spolo\u010dnosti Neuraxpharm zast\u00e1val nieko\u013eko ved\u00facich poz\u00edci\u00ed v oblasti rozvoja podnikania, ktor\u00e9 zah\u0155\u0148ali ude\u013eovanie licenci\u00ed v spolo\u010dnostiach Invent Farma a Hetero Europe a rozvoj poskytovania a predaja prostredn\u00edctvom strategick\u00fdch partnerstiev a aktiv\u00edt spolo\u010dnosti. Z\u00edskal bakal\u00e1rsky titul v odbore farm\u00e1cia na Barcelonskej univerzite a titul MBA na glob\u00e1lnom vzdel\u00e1vacom in\u0161tit\u00fate ESADE.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n je riadite\u013eom pre rozvoj podnikania a inov\u00e1cie a do spolo\u010dnosti Neuraxpharm nast\u00fapil v roku 2015, kde vytvoril a rozv\u00edjal firemn\u00e9 oddelenia rozvoja podnikania a licenci\u00ed, riadenia alianci\u00ed a potrubia. Miguel tie\u017e vedie oddelenia du\u0161evn\u00e9ho vlastn\u00edctva a zdravotn\u00edckych pom\u00f4cok. Miguel m\u00e1 25 rokov sk\u00fasenost\u00ed vo farmaceutickom priemysle na r\u00f4znych […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26239","page","type-page","status-publish","hentry"],"yoast_head":"\nMIGUEL BARRERO - Neuraxpharm SK<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL BARRERO\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n je riadite\u013eom pre rozvoj podnikania a inov\u00e1cie a do spolo\u010dnosti Neuraxpharm nast\u00fapil v roku 2015, kde vytvoril a rozv\u00edjal firemn\u00e9 oddelenia rozvoja podnikania a licenci\u00ed, riadenia alianci\u00ed a potrubia. Miguel tie\u017e vedie oddelenia du\u0161evn\u00e9ho vlastn\u00edctva a zdravotn\u00edckych pom\u00f4cok. Miguel m\u00e1 25 rokov sk\u00fasenost\u00ed vo farmaceutickom priemysle na r\u00f4znych […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm SK\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-09T10:55:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/sk\/wp-content\/uploads\/sites\/28\/2023\/03\/m-barrero.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 min\u00faty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero\",\"url\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero\",\"name\":\"MIGUEL BARRERO - Neuraxpharm SK\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/sk\/wp-content\/uploads\/sites\/28\/2023\/03\/m-barrero.jpg\",\"datePublished\":\"2023-02-10T09:19:25+00:00\",\"dateModified\":\"2025-09-09T10:55:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/28\/2023\/03\/27155230\/m-barrero.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/28\/2023\/03\/27155230\/m-barrero.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuraxpharm.com\/sk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O n\u00e1s\",\"item\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"V\u00fdkonn\u00e1 rada\",\"item\":\"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"MIGUEL BARRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/sk\/\",\"name\":\"Neuraxpharm SK\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/sk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MIGUEL BARRERO - Neuraxpharm SK","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero","og_locale":"sk_SK","og_type":"article","og_title":"MIGUEL BARRERO","og_description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n je riadite\u013eom pre rozvoj podnikania a inov\u00e1cie a do spolo\u010dnosti Neuraxpharm nast\u00fapil v roku 2015, kde vytvoril a rozv\u00edjal firemn\u00e9 oddelenia rozvoja podnikania a licenci\u00ed, riadenia alianci\u00ed a potrubia. Miguel tie\u017e vedie oddelenia du\u0161evn\u00e9ho vlastn\u00edctva a zdravotn\u00edckych pom\u00f4cok. Miguel m\u00e1 25 rokov sk\u00fasenost\u00ed vo farmaceutickom priemysle na r\u00f4znych […]","og_url":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero","og_site_name":"Neuraxpharm SK","article_modified_time":"2025-09-09T10:55:25+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/sk\/wp-content\/uploads\/sites\/28\/2023\/03\/m-barrero.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Predpokladan\u00fd \u010das \u010d\u00edtania":"2 min\u00faty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero","url":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero","name":"MIGUEL BARRERO - Neuraxpharm SK","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/sk\/wp-content\/uploads\/sites\/28\/2023\/03\/m-barrero.jpg","datePublished":"2023-02-10T09:19:25+00:00","dateModified":"2025-09-09T10:55:25+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/28\/2023\/03\/27155230\/m-barrero.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/28\/2023\/03\/27155230\/m-barrero.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite\/miguel-barrero#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/sk\/"},{"@type":"ListItem","position":2,"name":"O n\u00e1s","item":"https:\/\/www.neuraxpharm.com\/sk\/o-nas"},{"@type":"ListItem","position":3,"name":"V\u00fdkonn\u00e1 rada","item":"https:\/\/www.neuraxpharm.com\/sk\/o-nas\/directiecomite"},{"@type":"ListItem","position":4,"name":"MIGUEL BARRERO"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/sk\/#website","url":"https:\/\/www.neuraxpharm.com\/sk\/","name":"Neuraxpharm SK","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/sk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/26239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/comments?post=26239"}],"version-history":[{"count":14,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/26239\/revisions"}],"predecessor-version":[{"id":26652,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/26239\/revisions\/26652"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/media?parent=26239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}